A more personalised approach to hepatitis C treatment may improve adherence

A more personalised approach to hepatitis C treatment may improve adherence
The interviews aimed to explore each person's own understanding and experience of taking hepatitis C treatment, with questions about what it feels like to have hepatitis C, how the decision to take treatment was arrived at, their expectations of …
Read more here.

Project connects nurses tending to TB patients
Nurses who treat TB patients will meet by video with a team of physicians each month to discuss difficult cases and share their experiences with other nurses, said Dr. Bruce Struminger, an associate director of Project ECHO. “The whole purpose of …
Read more here.

Here's Why We Believe Gilead Sciences, Inc. (GILD) Stock Will Bounce Back
The bears highlight the likelihood that Gilead's revenue will suffer going forward; especially if a rival company is able to launch a drug that will treat hepatitis C in a much shorter duration than Gilead's Harvoni. They say that the US Food and Drug …
Read more here.

Cookies on the BBC website
The report looked at people in Scotland who were infected with blood-borne viruses – HIV and Hepatitis C – in the course of medical treatment on the NHS. The period scrutinised by the inquiry began on 1 January 1974 and ended on 1 September 1991, when …
Read more here.

Amends must be made to the victims of the contaminated blood scandal now
AFTER decades of campaigning, the decision to hold a public inquiry into what has been dubbed the biggest treatment disaster in the history of the NHS was welcomed by the victims who were infected with HIV and hepatitis C through contaminated blood.
Read more here.

Hepatitis C survivor slams Cameron's apology
A WOMAN from the New Forest infected with deadly hepatitis C in a contaminated blood scandal has criticised David Cameron's apology as too little, too late. Lesley Hughes was given 44 pints of blood in transfusions after suffering severe injuries …
Read more here.

FDA Approves Olysio-Sovaldi Hep C Combo
On November 5, the U.S. Food and Drug Administration granted approval of Olysio (simeprevir) and Sovaldi (sofosbuvir) to be used in combination for the treatment of genotype 1 of hepatitis C virus (HCV), Bloomberg News reports. … The Olysio-Sovaldi …
Read more here.

FDA Approves AbbVie's Hepatitis C Regimen Viekira Pak
On December 19, the U.S. Food and Drug Administration (FDA) approved AbbVie's hepatitis C virus (HCV) regimen Viekira Pak (ombitasvir/paritaprevir/ritonavir; dasabuvir) to treat genotype 1 of the virus, The Wall Street Journal reports. Formerly known …
Read more here.

Daclatasvir + sofosbuvir demonstrates good cure rate for genotype 3 hepatitis C
David Nelson from the University of Florida presented final results from the phase 3 ALLY-3 trial, which tested daclatasvir plus sofosbuvir in people with HCV genotype 3, including treatment-naive and treatment-experienced patients with and without …
Read more here.


Leave a Reply